Literature DB >> 14645446

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.

Halfdan Sørbye, Olav Dahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14645446     DOI： 10.1200/JCO.2003.99.200

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Cancer chemotherapy reduces plasma total polyphenols and total antioxidants capacity in colorectal cancer patients.

Authors:  R Santiago-Arteche; P Muñiz; M Cavia-Saiz; C Garcia-Giron; M García-Gonzalez; Beatriz Llorente-Ayala; M J Coma-Del Corral
Journal:  Mol Biol Rep       Date:  2012-07-08       Impact factor: 2.316

2.  Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.

Authors:  J Tie; I Kinde; Y Wang; H L Wong; J Roebert; M Christie; M Tacey; R Wong; M Singh; C S Karapetis; J Desai; B Tran; R L Strausberg; L A Diaz; N Papadopoulos; K W Kinzler; B Vogelstein; P Gibbs
Journal:  Ann Oncol       Date:  2015-04-07       Impact factor: 32.976

Review 3.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

4.  The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?

Authors:  Ryan M Thomas; Christian Jobin
Journal:  Trends Cancer       Date:  2015-09-01

Review 5.  Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.

Authors:  Maria F Arisi; Efrat Dotan; Sandra V Fernandez
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

6.  Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.

Authors:  Xuanzhang Huang; Peng Gao; Yongxi Song; Jingxu Sun; Xiaowan Chen; Junhua Zhao; Jing Liu; Huimian Xu; Zhenning Wang
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

7.  Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens.

Authors:  Antonia Martinetti; Rosalba Miceli; Elisa Sottotetti; Maria Di Bartolomeo; Filippo de Braud; Arpine Gevorgyan; Katia Fiorella Dotti; Emilio Bajetta; Manuela Campiglio; Francesca Bianchi; Giacomo Bregni; Filippo Pietrantonio
Journal:  Cancers (Basel)       Date:  2014-08-29       Impact factor: 6.639

8.  Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells.

Authors:  Hsin-chung Lee; Qing-Dong Ling; Wan-Chun Yu; Chunh-Ming Hung; Ta-Chun Kao; Yi-Wei Huang; Akon Higuchi
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

9.  Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.

Authors:  C-Y Lu; H-L Tsai; Y-H Uen; H-M Hu; C-W Chen; T-L Cheng; S-R Lin; J-Y Wang
Journal:  Br J Cancer       Date:  2013-02-19       Impact factor: 7.640

10.  Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.

Authors:  Fotios Loupakis; Shruti Sharma; Madiha Derouazi; Sabina Murgioni; Paola Biason; Mario Domenico Rizzato; Cosimo Rasola; Derrick Renner; Svetlana Shchegrova; Allyson Koyen Malashevich; Meenakshi Malhotra; Himanshu Sethi; Bernhard G Zimmermann; Alexey Aleshin; Solomon Moshkevich; Paul R Billings; Jonathon D Sedgwick; Marta Schirripa; Giada Munari; Umberto Cillo; Pierluigi Pilati; Angelo Paolo Dei Tos; Vittorina Zagonel; Sara Lonardi; Matteo Fassan
Journal:  JCO Precis Oncol       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.